Massimo Bogliolo

2.0k total citations
28 papers, 740 citations indexed

About

Massimo Bogliolo is a scholar working on Molecular Biology, Cancer Research and Genetics. According to data from OpenAlex, Massimo Bogliolo has authored 28 papers receiving a total of 740 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 12 papers in Cancer Research and 6 papers in Genetics. Recurrent topics in Massimo Bogliolo's work include DNA Repair Mechanisms (23 papers), CRISPR and Genetic Engineering (10 papers) and Carcinogens and Genotoxicity Assessment (10 papers). Massimo Bogliolo is often cited by papers focused on DNA Repair Mechanisms (23 papers), CRISPR and Genetic Engineering (10 papers) and Carcinogens and Genotoxicity Assessment (10 papers). Massimo Bogliolo collaborates with scholars based in Spain, Italy and United States. Massimo Bogliolo's co-authors include Jordi Surrallés, Marı́a José Ramı́rez, Enrico Cappelli, Roser Pujol, Detlev Schindler, Kornelia Neveling, Elsa Callén, Alex Lyakhovich, María Castellà and Ricard Marcos and has published in prestigious journals such as Nucleic Acids Research, The EMBO Journal and Blood.

In The Last Decade

Massimo Bogliolo

28 papers receiving 732 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Massimo Bogliolo Spain 16 608 170 165 122 59 28 740
Zi-Qiang Zhou United States 11 780 1.3× 113 0.7× 234 1.4× 212 1.7× 44 0.7× 11 854
Ángel Martínez‐Ramírez Spain 17 564 0.9× 159 0.9× 153 0.9× 122 1.0× 90 1.5× 26 843
Takeshi Ariyama Japan 14 428 0.7× 165 1.0× 99 0.6× 99 0.8× 75 1.3× 29 708
Koichi R. Katsumura United States 18 578 1.0× 98 0.6× 87 0.5× 107 0.9× 76 1.3× 24 863
Pia Huusko Finland 12 418 0.7× 267 1.6× 170 1.0× 120 1.0× 47 0.8× 13 585
Emmanuel Tubacher France 8 465 0.8× 131 0.8× 170 1.0× 95 0.8× 19 0.3× 11 708
Marcin M. Gorski Italy 11 887 1.5× 64 0.4× 219 1.3× 177 1.5× 56 0.9× 15 1.1k
Senthilkumar Cinghu United States 12 706 1.2× 54 0.3× 156 0.9× 136 1.1× 33 0.6× 16 842
Paula Gutierrez‐Martinez Spain 10 763 1.3× 106 0.6× 138 0.8× 360 3.0× 100 1.7× 12 1.0k
Evelyn Despierre Belgium 13 420 0.7× 103 0.6× 298 1.8× 156 1.3× 27 0.5× 17 914

Countries citing papers authored by Massimo Bogliolo

Since Specialization
Citations

This map shows the geographic impact of Massimo Bogliolo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Massimo Bogliolo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Massimo Bogliolo more than expected).

Fields of papers citing papers by Massimo Bogliolo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Massimo Bogliolo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Massimo Bogliolo. The network helps show where Massimo Bogliolo may publish in the future.

Co-authorship network of co-authors of Massimo Bogliolo

This figure shows the co-authorship network connecting the top 25 collaborators of Massimo Bogliolo. A scholar is included among the top collaborators of Massimo Bogliolo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Massimo Bogliolo. Massimo Bogliolo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Castells‐Roca, Laia, Sara Gutiérrez‐Enríquez, Sandra Bonache, et al.. (2021). Clinical consequences of BRCA2 hypomorphism. npj Breast Cancer. 7(1). 117–117. 6 indexed citations
2.
Roman‐Rodriguez, Francisco J, Lara Álvarez, Begoña Díez, et al.. (2019). NHEJ-Mediated Repair of CRISPR-Cas9-Induced DNA Breaks Efficiently Corrects Mutations in HSPCs from Patients with Fanconi Anemia. Cell stem cell. 25(5). 607–621.e7. 69 indexed citations
3.
Ramı́rez, Marı́a José, Miriam Aza‐Carmona, Nan Jia, et al.. (2019). Functional Comparison of XPF Missense Mutations Associated to Multiple DNA Repair Disorders. Genes. 10(1). 60–60. 9 indexed citations
4.
Krausz, Csilla, Antoni Riera‐Escamilla, Chiara Chianese, et al.. (2018). From exome analysis in idiopathic azoospermia to the identification of a high-risk subgroup for occult Fanconi anemia. Genetics in Medicine. 21(1). 189–194. 29 indexed citations
5.
Bogliolo, Massimo, Dominique Bluteau, James Lespinasse, et al.. (2017). Biallelic truncating FANCM mutations cause early-onset cancer but not Fanconi anemia. Genetics in Medicine. 20(4). 458–463. 54 indexed citations
6.
Bogliolo, Massimo & Jordi Surrallés. (2015). Fanconi anemia: a model disease for studies on human genetics and advanced therapeutics. Current Opinion in Genetics & Development. 33. 32–40. 132 indexed citations
7.
Bogliolo, Massimo, et al.. (2015). Activation of the Fanconi anemia/BRCA pathway at low doses of ionization radiation. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 793. 9–13. 4 indexed citations
8.
Bogliolo, Massimo, et al.. (2011). Coordinated action of the Fanconi anemia and ataxia telangiectasia pathways in response to oxidative damage. DNA repair. 10(5). 518–525. 19 indexed citations
9.
Naim, Valeria, Paola Caruso, Romina Burla, et al.. (2011). The FANC pathway is activated by adenovirus infection and promotes viral replication-dependent recombination. Nucleic Acids Research. 39(13). 5459–5473. 12 indexed citations
10.
Bogliolo, Massimo, Alex Lyakhovich, Elsa Callén, et al.. (2007). Histone H2AX and Fanconi anemia FANCD2 function in the same pathway to maintain chromosome stability. The EMBO Journal. 26(5). 1340–1351. 102 indexed citations
11.
Bogliolo, Massimo, et al.. (2005). 3R coordination by Fanconi anemia proteins. Biochimie. 87(7). 647–658. 20 indexed citations
12.
Cappelli, Enrico, Andrea D’Osualdo, Massimo Bogliolo, Mark R. Kelley, & Guido Fròsina. (2003). Drosophila S3 ribosomal protein accelerates repair of 8‐oxoguanine performed by human and mouse cell extracts. Environmental and Molecular Mutagenesis. 42(1). 50–58. 12 indexed citations
13.
Cappelli, Enrico, Andrea D’Osualdo, Massimo Bogliolo, et al.. (2003). Repair of 8 oxoguanine in mammalian cells expressing the Drosophila S3 ribosomal/repair protein. Teratogenesis Carcinogenesis and Mutagenesis. 23(S1). 113–121. 2 indexed citations
14.
Bogliolo, Massimo. (2002). The Fanconi anaemia genome stability and tumour suppressor network. Mutagenesis. 17(6). 529–538. 42 indexed citations
15.
Bogliolo, Massimo. (2002). Alternative metabolic pathways for energy supply and resistance to apoptosis in Fanconi anaemia. Mutagenesis. 17(1). 25–30. 19 indexed citations
16.
Bogliolo, Massimo, Richard Taylor, Keith W. Caldecott, & Guido Fròsina. (2000). Reduced ligation during DNA base excision repair supported by BRCA2 mutant cells. Oncogene. 19(50). 5781–5787. 18 indexed citations
17.
Bogliolo, Massimo. (1999). Detection of the `4977 bp' mitochondrial DNA deletion in human atherosclerotic lesions. Mutagenesis. 14(1). 77–82. 40 indexed citations
18.
Campomenosi, Paola, Massimo Bogliolo, Gilberto Fronza, et al.. (1998). p53 Mutations and DNA Ploidy in Colorectal Adenocarcinomas. Analytical Cellular Pathology. 17(1). 1–12. 15 indexed citations
19.
Campomenosi, Paola, Gilberto Fronza, Laura Ottaggio, et al.. (1997). Heterogeneousp53 mutations in a Burkitt lymphoma from an AIDS patient with monoclonalc-myc andVDJ rearrangements. International Journal of Cancer. 73(6). 816–821. 4 indexed citations
20.
Campomenosi, Paola, Laura Ottaggio, Francesca Moro, et al.. (1996). Study on aneuploidy and p53 mutations in astrocytonias. Cancer Genetics and Cytogenetics. 88(2). 95–102. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026